AK-2292

N/A

Report date: 2023/03/06 14:28:47
NME

Base Information

Drug NameAK-2292
Drug Alias NameAK-2292
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionSignal transducer and activator of transcription 5B degradersSignal transducer and activator of transcription 5A degraders
TargetsSignal transducer and activator of transcription 5BSignal transducer and activator of transcription 5A
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Michigan
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A